Jane Wang, PhD

VP and Head of Delivery and Process Devlopment at Tessera Therapeutics

Speaker

Jane is the Vice President and Head of Delivery Technologies and Process Development at Tessera Therapeutics where she works on technology development to enable in vivo gene editing therapies. Prior to joining Tessera, she was technical lead of the nanoparticle program at Verily Life Sciences, where she worked on a variety of delivery technologies including LNP barcoding and extrahepatic nanoparticle delivery. Her background is in drug delivery, chemistry and enzyme engineering and she holds a PhD in Chemistry from UC Berkeley and a BS from the California Institute of Technology in Chemistry.